QT
AERI

Quantamental Technologies’s Aerie Pharmaceuticals AERI Stock Holding History

Quantamental Technologies’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,314
Closed -$160K – 1496
2019
Q3 		$160K Buy
+8,314
New +$190K 0.05% 576
2019
Q2 		– Sell
-855
Closed -$41K – 1911
2019
Q1 		$41K Buy
+855
New +$37.6K 0.02% 924

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quantamental Technologies's AERI Position: Q4 2019 in Review

Quantamental Technologies sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 8,314 shares — an estimated $160K sold.

Quantamental Technologies first reported a position in AERI in Q1 2019 and held it in 2 quarters. The position peaked at $160K in Q3 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • Quantamental Technologies reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 8,314 Aerie Pharmaceuticals shares in Q4 2019, an estimated $160K.
  • Quantamental Technologies first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Quantamental Technologies's Aerie Pharmaceuticals position peaked at $160K in Q3 2019.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.